Skip to content
Peptide research

Cardiogen

Category
Bioregulators
Administration routes
InjectableOral
Regulatory status
Not FDA-approved

What it is

A short synthetic bioregulator peptide marketed for heart health and cardiac anti-aging. Evidence is almost entirely animal and cell-culture: reduced heart-cell death and better survival after induced heart injury, with human data essentially absent. Animal work also shows it altering tumor-cell behavior, an unresolved concern for undiagnosed cancer, with no human safety record. Not an approved drug in the US; supply is unregulated research-grade material.

Read Full record

Studied uses & evidence

Studied uses(11)

  • Stimulates expression of cytoskeletal proteins (actin, tubulin, vimentin) by 2-5x in fibroblast cultures

    Speculative

    Single mouse embryonic fibroblast study only, not replicated, not cardiac tissue.

  • Enhances nuclear matrix protein expression (lamin A, lamin C) by 2-3x

    Speculative

    Same single embryonic fibroblast experiment, no independent confirmation or human data.

  • Stimulates cardiomyocyte proliferation in organotypic tissue cultures from both young and aged animals

    Low

    Two ex vivo rat tissue culture studies show increased proliferation in young and aged hearts.

Evidence limits

Evidence Level
Preclinical

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(8)

Risks = level of concern: High · Moderate · Low · Theoretical

  • safety_data

    Moderate
  • Unknown long-term safety profile in humans

    Moderate
  • Possible immunogenic reactions (as with any exogenous peptide)

    Low
  • Potential unknown interactions with cardiovascular medications

    Theoretical
  • Gene expression modulation effects could theoretically have unintended consequences

    Theoretical
  • Tumor-modifying activity observed in animal models raises questions about effects in patients with undiagnosed cancers

    Moderate
  • contraindications

    Moderate
  • note

    Low
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.